Inaldin Gardło (Benzydamine Hydrochloride)

Benzydamine hydrochloride acts by inhibiting pro‑inflammatory cytokines, stabilising cell membranes and providing a mild local anesthetic effect. This combination reduces inflammation, pain and microbial growth at the site of application.

The dosage of Inaldin Gardło is determined by the prescribing healthcare professional based on the patient’s age, condition severity and formulation. Patients should follow the prescriber’s instructions and the product label.

Safety information for pregnancy and breastfeeding has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Inaldin Gardło with their healthcare provider before starting treatment.

To order Inaldin Gardło, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Inaldin Gardło’s active ingredient, benzydamine hydrochloride, offers a combined anti‑inflammatory, analgesic and antiseptic effect, which differs from simple analgesics or antiseptic lozenges. It provides both pain relief and reduction of inflammation, making it useful for conditions where swelling and discomfort coexist.

Store Inaldin Gardło at room temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Inaldin Gardło is applied directly to the oral cavity or throat according to the prescriber’s directions. The product is typically used as a spray, gargle or lozenge, allowing the medication to coat the affected area for local action.

Serious risks, although rare, include allergic reactions such as rash, swelling, or difficulty breathing, and severe mucosal ulceration. Patients should stop use and seek medical attention immediately if any of these symptoms occur.

Individuals with a known hypersensitivity to benzydamine hydrochloride or any component of the formulation should avoid using Inaldin Gardło. Patients with severe oral lesions or those advised against topical oral medications by their clinician should also refrain from use.